Oral Non Hodgkin’s Lymphoma : Case Report
Abstract
Non Hodgkin’s lymphoma is common malignancy seen in HIV patient. This case report presents NHL case in Thai patient who came to see the dentist with complaint of “mass in the mouth”. The dentist assumes a main role in detecting early stage this manifestation. This report also reveals a diagnostic approach of NHL subtype using immunohistochemistry and in situ hybridization of EBV. Complete follow up of case is also presented.
References
1. Epstein, J. B., Epstein, J.D., Le, N. D., & Gorsky, M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92(5),519-25. (cite 2015 Jan, 15) Available From: doi:10.1067/moe.2001.116062
2. Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45(4-5),309-16. (cite 2015 Jan, 15) Available From: doi:10.1016/j.oraloncology. 2008.06.002
3. Carbone, A., Cesarman, E., Spina, M., Gloghini, A., & Schulz, T.F. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009;113(6),1213-24. (cite 2015 Jan,9) Available From: doi: 10.1182/blood-2008-09-180315
4. Kemp, S., Gallagher, G., Kabani, S., Noonan, V., & O’Hara, C. Oral non-Hodgkin’s lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 2008;105(2), 194-201. (cite 2015 Jan,9) Available From: doi:10.1016/j.tripleo.2007.02.019
5. Etemad-Moghadam, S., Tirgary, F., Keshavarz, S., & Alaeddini, M. Head and neck non- Hodgkin’s lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg 2010;39(9),869-72. (cite 2015 Jan, 20) Available From: doi:10.1016/j.ijom.2010.03.029
6. Boulaadas, M., Benazzou, S., Sefiani, S., Nazih, N., Essakalli, L., & Kzadri, M. Primary extranodal non-Hodgkin lymphoma of the oral cavity. J Craniofac Surg 2008;19(4),1183-5.doi:10.1097/SCS.0b013e3181764b56
7. Ramanathan, A., Rahman Mahmoud, H.A., Hui, L. P., Mei, N.Y.,Valliappan, V.,& Zain, R.B. Oral Extranodal Non Hodgkin’s Lymphoma:Series of Forty Two Cases in Malaysia. Asian Pac J Cancer Prev 2014;15(4),1633-7.
8. Epstein, J.B. Oral malignancies associated with HIV. J Can Dent Assoc 2007;73(10),953-6.
9. Cuttner, J., Spiera, H., Troy, K.,& Wallenstein, S. Autoimmune disease is a risk factor for the development of non-Hodgkin’s lymphoma. J Rheumatol 2005;32(10),1884-7.
10. Fisher, S.G., & Fisher, R.I. The epidemiology of non-Hodgkin’s lymphoma. Oncogene 2004;23(38),6524-34. (cite 2015 Feb,2) Available from:doi:10.1038/sj.onc.1207843
11. Kiertiburanakul, S., Likhitpongwit, S., Ratanasiri, S., & Sungkanuparph, S. Malignancies in HIV-infected Thai patients. HIV Med 2007;8(5),322-23. (cite 2015 Feb,2) Available From: doi:10.1111/j.1468-1293.2007.00471.x
12. Nisa Makruasi, Pimjai Niparuck, Somnuek Sungkanuparph, Artit Ungkanont, Wasana Kanoksil, Paisarn Boonsakan et al, Non Hodgkin’s Lymphoma (NHL) in HIV Infected
Patients in Thailand 2011 J INFECT DIS ANTIMICROB AGENTS 2011;(Jan.-April),5-14.
13. Carbone, A., & Gloghini, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005;130(5),662-70. (cite 2015 Feb,2) Available From:doi: 10.1111/j.1365-2141.2005.05613.x
14. Gaidano, G., & Carbone, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 1995;90(2),235-43.
15. Sharma, M., Mannan, R., Madhukar, M., Navani, S., Manjari, M., Bhasin,T.S., & Gill, K.S. Immunohistochemical (IHC) Analysis of Non-Hodgkin’s Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India. J Clin Diagn Res 2014;8(1),46-9. (cite 2015 Feb,8) Available From: doi:10.7860/JCDR/2014/8173.3988
16. van der Waal, R.I., Huijgens, P.C., van der Valk, P., & van der Waal, I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005;34(4),391-5. (cite 2015 Feb,8) Available From:doi:10.1016/j.ijom.2004.08.009
17. Souto, G.R., Pereira, T.S., Castro, A.F.,& Mesquita, R.A.Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report. J Clin Exp Dent 2013;5(5),e287-90. (cite 2015 Feb,8) Available From:doi:10.4317/jced.51127
18. Bulut,E., Bekcioglu,B., Gunhan, O., & Sener, I. Diffuse large B-cell lymphoma with oral manifestations. J Craniofac Surg 2011;22(3),1144-7.(cite 2015 Feb,8) Available From:doi:10.1097/SCS.0b013e318210b940
19. Pileri, S.A., Dirnhofer, S.,Went, P., Ascani, S., Sabattini, E., Marafioti, T.,et al. Diffuse large B-cell lymphoma:one or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002;41(6),482-509.
20. Iamaroon, A., Pongsiriwet, S., Mahanupab,P.,Kitikamthon, R., & Pintong, J. (1982). Oral non-Hodgkin lymphomas: studies of EBV and p53 expression. Oral Dis 1982;9(1),14-8.
21. Chadburn A, Chiu A,& JY, L.(2009). Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol, 27,27:5039-48.
22. Shimizu, K., Hara, K., & Kunii, A. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin’s lymphoma. Am J Clin Oncol 1989;12(3),195-200
23. Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J.C., Thomas, J., et al. (1998). CHOP is the standard regimen in patients>or = 70 years of age with intermediate-grade and high-grade non-Hodgkin’s lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998;16(1),27-34.
24. Kamath, S.S., Marcus, R.B., Jr., Lynch, J. W., & Mendenhall, N.P. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in
stage I and II non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 1999;44(3),563-8.
25. Whelton, S. Radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma. Nurse Pract 2007;32(12),35-8. (cite 2015 Feb,8) Available From:doi:10.1097/01.NPR.0000300826.51593.f4
2. Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45(4-5),309-16. (cite 2015 Jan, 15) Available From: doi:10.1016/j.oraloncology. 2008.06.002
3. Carbone, A., Cesarman, E., Spina, M., Gloghini, A., & Schulz, T.F. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009;113(6),1213-24. (cite 2015 Jan,9) Available From: doi: 10.1182/blood-2008-09-180315
4. Kemp, S., Gallagher, G., Kabani, S., Noonan, V., & O’Hara, C. Oral non-Hodgkin’s lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 2008;105(2), 194-201. (cite 2015 Jan,9) Available From: doi:10.1016/j.tripleo.2007.02.019
5. Etemad-Moghadam, S., Tirgary, F., Keshavarz, S., & Alaeddini, M. Head and neck non- Hodgkin’s lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg 2010;39(9),869-72. (cite 2015 Jan, 20) Available From: doi:10.1016/j.ijom.2010.03.029
6. Boulaadas, M., Benazzou, S., Sefiani, S., Nazih, N., Essakalli, L., & Kzadri, M. Primary extranodal non-Hodgkin lymphoma of the oral cavity. J Craniofac Surg 2008;19(4),1183-5.doi:10.1097/SCS.0b013e3181764b56
7. Ramanathan, A., Rahman Mahmoud, H.A., Hui, L. P., Mei, N.Y.,Valliappan, V.,& Zain, R.B. Oral Extranodal Non Hodgkin’s Lymphoma:Series of Forty Two Cases in Malaysia. Asian Pac J Cancer Prev 2014;15(4),1633-7.
8. Epstein, J.B. Oral malignancies associated with HIV. J Can Dent Assoc 2007;73(10),953-6.
9. Cuttner, J., Spiera, H., Troy, K.,& Wallenstein, S. Autoimmune disease is a risk factor for the development of non-Hodgkin’s lymphoma. J Rheumatol 2005;32(10),1884-7.
10. Fisher, S.G., & Fisher, R.I. The epidemiology of non-Hodgkin’s lymphoma. Oncogene 2004;23(38),6524-34. (cite 2015 Feb,2) Available from:doi:10.1038/sj.onc.1207843
11. Kiertiburanakul, S., Likhitpongwit, S., Ratanasiri, S., & Sungkanuparph, S. Malignancies in HIV-infected Thai patients. HIV Med 2007;8(5),322-23. (cite 2015 Feb,2) Available From: doi:10.1111/j.1468-1293.2007.00471.x
12. Nisa Makruasi, Pimjai Niparuck, Somnuek Sungkanuparph, Artit Ungkanont, Wasana Kanoksil, Paisarn Boonsakan et al, Non Hodgkin’s Lymphoma (NHL) in HIV Infected
Patients in Thailand 2011 J INFECT DIS ANTIMICROB AGENTS 2011;(Jan.-April),5-14.
13. Carbone, A., & Gloghini, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005;130(5),662-70. (cite 2015 Feb,2) Available From:doi: 10.1111/j.1365-2141.2005.05613.x
14. Gaidano, G., & Carbone, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 1995;90(2),235-43.
15. Sharma, M., Mannan, R., Madhukar, M., Navani, S., Manjari, M., Bhasin,T.S., & Gill, K.S. Immunohistochemical (IHC) Analysis of Non-Hodgkin’s Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India. J Clin Diagn Res 2014;8(1),46-9. (cite 2015 Feb,8) Available From: doi:10.7860/JCDR/2014/8173.3988
16. van der Waal, R.I., Huijgens, P.C., van der Valk, P., & van der Waal, I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005;34(4),391-5. (cite 2015 Feb,8) Available From:doi:10.1016/j.ijom.2004.08.009
17. Souto, G.R., Pereira, T.S., Castro, A.F.,& Mesquita, R.A.Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report. J Clin Exp Dent 2013;5(5),e287-90. (cite 2015 Feb,8) Available From:doi:10.4317/jced.51127
18. Bulut,E., Bekcioglu,B., Gunhan, O., & Sener, I. Diffuse large B-cell lymphoma with oral manifestations. J Craniofac Surg 2011;22(3),1144-7.(cite 2015 Feb,8) Available From:doi:10.1097/SCS.0b013e318210b940
19. Pileri, S.A., Dirnhofer, S.,Went, P., Ascani, S., Sabattini, E., Marafioti, T.,et al. Diffuse large B-cell lymphoma:one or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002;41(6),482-509.
20. Iamaroon, A., Pongsiriwet, S., Mahanupab,P.,Kitikamthon, R., & Pintong, J. (1982). Oral non-Hodgkin lymphomas: studies of EBV and p53 expression. Oral Dis 1982;9(1),14-8.
21. Chadburn A, Chiu A,& JY, L.(2009). Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol, 27,27:5039-48.
22. Shimizu, K., Hara, K., & Kunii, A. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin’s lymphoma. Am J Clin Oncol 1989;12(3),195-200
23. Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J.C., Thomas, J., et al. (1998). CHOP is the standard regimen in patients>or = 70 years of age with intermediate-grade and high-grade non-Hodgkin’s lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998;16(1),27-34.
24. Kamath, S.S., Marcus, R.B., Jr., Lynch, J. W., & Mendenhall, N.P. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in
stage I and II non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 1999;44(3),563-8.
25. Whelton, S. Radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma. Nurse Pract 2007;32(12),35-8. (cite 2015 Feb,8) Available From:doi:10.1097/01.NPR.0000300826.51593.f4
Downloads
Published
2019-01-10
How to Cite
1.
เสกธีระ ก, ทรัพยะโตษก ไ, รังสิยานนท์ ส, บุญสะกันต์ ไ. Oral Non Hodgkin’s Lymphoma : Case Report. JPMAT [Internet]. 2019 Jan. 10 [cited 2024 Nov. 24];5(2):188-95. Available from: https://he01.tci-thaijo.org/index.php/JPMAT/article/view/165702
Issue
Section
Case Report
License
บทความที่ลงพิมพ์ในวารสารเวชศาสตร์ป้องกันแห่งประเทศไทย ถือเป็นผลงานวิชาการ งานวิจัย วิเคราะห์ วิจารณ์ เป็นความเห็นส่วนตัวของผู้นิพนธ์ กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยเสมอไปและผู้นิพนธ์จะต้องรับผิดชอบต่อบทความของตนเอง
